Immunome, Inc. · 2 months ago
Senior Director, Global Regulatory Lead
Immunome is a clinical-stage targeted oncology company committed to developing innovative therapies for cancer patients. The Global Regulatory Lead will be responsible for the development and execution of global regulatory strategies, ensuring compliance and driving the regulatory success of products in development throughout their life cycle.
BiopharmaBiotechnologyMedicalPharmaceutical
Responsibilities
Define and implement global regulatory strategies that adapt to changing regulatory and business needs
Communicate key developments to project teams and stakeholders, ensuring alignment and sound judgment
Anticipate risks and devise solutions, understanding the likelihood of technical success for proposed strategies
Lead the Global Regulatory Team, fostering a high-performance culture through coaching and mentoring
Collaborate with regional regulatory leads and vendors to ensure compliance with local regulations for global submissions
Communicate effectively with internal and external partners, advocating for regulatory positions in governance and cross-functional committees
Identify regulatory risks and opportunities, developing strategies to mitigate risks and enhance success rates
Ensure timely preparation and submission of regulatory submissions (e.g., INDs, BLAs, NDAs) while maintaining compliance with regional and global requirements
Act as the primary contact with global health authorities and lead FDA meetings
Monitor industry trends and regulatory changes, adapting strategies to mitigate impacts on product development
Qualification
Required
Bachelor's degree in a relevant scientific discipline
A minimum of 10 years experience in global regulatory affairs in the pharmaceutical/biotechnology industry
Proven success in leading regulatory submissions and obtaining approvals in major markets
Direct experience leading regulatory submissions, health authority meetings and interactions with in-depth knowledge of the internal operations and outlook of the FDA, EMA and other global health authorities
Has a comprehensive and disciplined approach to regulatory risk management and compliance through deep expertise and understanding of the oncology therapeutic area
Highly collaborative self-starter and team player who fosters open communication and facilitates mutual understanding and cooperation between all stakeholders
Outstanding communication, analytical, organizational and time management skills
Experience and passion to work with small teams, ability to work comfortably under pressure under evolving scenarios and tight deadlines
Detail-minded yet flexible work style; manage multiple projects and timelines simultaneously, and rapidly change priorities based on business needs
Preferred
Experience developing oncology therapeutics is strongly preferred
Company
Immunome, Inc.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
Funding
Current Stage
Public CompanyTotal Funding
$998.85MKey Investors
JPEO-CBRNDU.S. Department of DefenseRobin Hood Ventures
2025-12-16Post Ipo Equity· $400M
2025-01-29Post Ipo Equity· $150M
2024-02-13Post Ipo Equity· $230M
Recent News
2026-01-09
BioWorld Financial Watch
2025-12-19
Company data provided by crunchbase